These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 36627212)
1. Time to Change: A Systems Pharmacology Approach to Disentangle Mechanisms of Drug-Induced Mitochondrial Toxicity. Hoogstraten CA; Lyon JJ; Smeitink JAM; Russel FGM; Schirris TJJ Pharmacol Rev; 2023 May; 75(3):463-486. PubMed ID: 36627212 [TBL] [Abstract][Full Text] [Related]
2. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Singh SS Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106 [TBL] [Abstract][Full Text] [Related]
3. Investigating mitochondrial dysfunction to increase drug safety in the pharmaceutical industry. Nadanaciva S; Will Y Curr Drug Targets; 2011 Jun; 12(6):774-82. PubMed ID: 21275886 [TBL] [Abstract][Full Text] [Related]
4. New insights in drug-induced mitochondrial toxicity. Nadanaciva S; Will Y Curr Pharm Des; 2011; 17(20):2100-12. PubMed ID: 21718246 [TBL] [Abstract][Full Text] [Related]
5. The significance of mitochondrial toxicity testing in drug development. Dykens JA; Will Y Drug Discov Today; 2007 Sep; 12(17-18):777-85. PubMed ID: 17826691 [TBL] [Abstract][Full Text] [Related]
7. Role of systems pharmacology in understanding drug adverse events. Berger SI; Iyengar R Wiley Interdiscip Rev Syst Biol Med; 2011; 3(2):129-35. PubMed ID: 20803507 [TBL] [Abstract][Full Text] [Related]
8. Systems pharmacology modeling: an approach to improving drug safety. Bai JP; Fontana RJ; Price ND; Sangar V Biopharm Drug Dispos; 2014 Jan; 35(1):1-14. PubMed ID: 24136298 [TBL] [Abstract][Full Text] [Related]
9. Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity. Sangar MC; Bansal S; Avadhani NG Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1231-51. PubMed ID: 20629582 [TBL] [Abstract][Full Text] [Related]
10. A combined in vitro approach to improve the prediction of mitochondrial toxicants. Eakins J; Bauch C; Woodhouse H; Park B; Bevan S; Dilworth C; Walker P Toxicol In Vitro; 2016 Aug; 34():161-170. PubMed ID: 27083147 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of drug toxicity and relevance to pharmaceutical development. Guengerich FP Drug Metab Pharmacokinet; 2011; 26(1):3-14. PubMed ID: 20978361 [TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
13. Characterization of drug-induced human mitochondrial ADP/ATP carrier inhibition. Jaiquel Baron S; King MS; Kunji ERS; Schirris TJJ Theranostics; 2021; 11(11):5077-5091. PubMed ID: 33859735 [TBL] [Abstract][Full Text] [Related]
14. Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation. Tang X; Wang Z; Hu S; Zhou B Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890211 [TBL] [Abstract][Full Text] [Related]
15. Screening for the potential of a drug candidate to cause idiosyncratic drug reactions. Uetrecht J Drug Discov Today; 2003 Sep; 8(18):832-7. PubMed ID: 12963319 [TBL] [Abstract][Full Text] [Related]
16. Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology. Moya-García AA; González-Jiménez A; Moreno F; Stephens C; Lucena MI; Ranea JAG Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886075 [TBL] [Abstract][Full Text] [Related]
17. Electrically wired mitochondrial electrodes for measuring mitochondrial function for drug screening. Arechederra RL; Waheed A; Sly WS; Minteer SD Analyst; 2011 Sep; 136(18):3747-52. PubMed ID: 21776494 [TBL] [Abstract][Full Text] [Related]
18. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456 [TBL] [Abstract][Full Text] [Related]
19. Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus. De Vries MC; Brown DA; Allen ME; Bindoff L; Gorman GS; Karaa A; Keshavan N; Lamperti C; McFarland R; Ng YS; O'Callaghan M; Pitceathly RDS; Rahman S; Russel FGM; Varhaug KN; Schirris TJJ; Mancuso M J Inherit Metab Dis; 2020 Jul; 43(4):800-818. PubMed ID: 32030781 [TBL] [Abstract][Full Text] [Related]